Due to the special nature of medicines, returns and exchanges are not supported.

Final delivery from the nearest overseas warehous NEW

Erleada（apalutamide）安森珂(阿帕他胺）

Treated patients with non-metastatic castration-resistant prostate cancer (nmCRPC) demonstrate robust prostate-specific antigen (PSA) responses and high medication compliance rates

Categories: Oncology drugs, reproductive / urinary

Share:

Health Classification

Let us work together to protect precious health

More